Arco Y. Jeng

Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)

Jessie Gu, Adele Noè, Priya Chandra et al. · The Journal of Clinical Pharmacology · 2009 · 502 citations

Medicine, Pharmacokinetics, Pharmacology +17

Mechanism of action of the phorbol ester tumor promoters: Specific receptors for lipophilic ligands

Peter M. Blumberg, Susan Jaken, Bernhard König et al. · Biochemical Pharmacology · 1984 · 205 citations

Life Sciences, Biochemistry, Pharmacology +14

Comparison of protein kinase C functional assays to clarify mechanisms of inhibitor action

Teruo Nakadate, Arco Y. Jeng, Peter M. Blumberg · Biochemical Pharmacology · 1988 · 191 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +14

Aldosterone Synthase Inhibitor Ameliorates Angiotensin II–Induced Organ Damage

Anette Fiebeler, Jürg Nussberger, Erdenechimeg Shagdarsuren et al. · Circulation · 2005 · 179 citations · Full text

Medicine, Endocrinology, Pharmacology +16

Effect of Matrix Metalloproteinase Inhibition on Progression of Atherosclerosis and Aneurysm in LDL Receptor‐Deficient Mice Overexpressing MMP‐3, MMP‐12, and MMP‐13 and on Restenosis in Rats after Balloon Injury

Margaret F. Prescott, Wilbur K. Sawyer, JEAN VON LINDEN‐REED et al. · Annals of the New York Academy of Sciences · 1999 · 143 citations

Medicine, Cardiology, Pharmacology +14